Showing results (1-10 of 35) with videos related to
Sort By:
Pageof 4
Npj Antimicrobials and Resistance|April 30, 2026
Overcoming Trypanosoma cruzi persistence with a mechanistically distinct drug combinationAmanda Fortes Francisco, Francisco Olmo, Fanny Escudié, et al.Journal of Biomolecular Screening|October 10, 2014
A new experimental model for assessing drug efficacy against Trypanosoma cruzi infection based on highly sensitive in vivo imagingMichael D Lewis, Amanda Fortes Francisco, Martin C Taylor, et al.Antimicrobial Agents and Chemotherapy|August 8, 2018
Assessing the Effectiveness of Curative Benznidazole Treatment in Preventing Chronic Cardiac Pathology in Experimental Models of Chagas DiseaseAmanda Fortes Francisco, Shiromani Jayawardhana, Martin C Taylor, et al.Cellular Microbiology|February 27, 2016
Host and parasite genetics shape a link between Trypanosoma cruzi infection dynamics and chronic cardiomyopathyMichael D Lewis, Amanda Fortes Francisco, Martin C Taylor, et al.Plos Neglected Tropical Diseases|April 16, 2015
The Trypanosoma cruzi vitamin C dependent peroxidase confers protection against oxidative stress but is not a determinant of virulenceMartin C Taylor, Michael D Lewis, Amanda Fortes Francisco, et al.Antimicrobial Agents and Chemotherapy|May 28, 2015
Limited Ability of Posaconazole To Cure both Acute and Chronic Trypanosoma cruzi Infections Revealed by Highly Sensitive In Vivo ImagingAmanda Fortes Francisco, Michael D Lewis, Shiromani Jayawardhana, et al.International Journal of Molecular Sciences|July 2, 2021
Image-Based In Vitro Screening Reveals the Trypanostatic Activity of Hydroxymethylnitrofurazone against Trypanosoma cruziCauê Benito Scarim, Francisco Olmo, Elizabeth Igne Ferreira, et al.Microbial Pathogenesis|September 7, 2019
Intestinal microbiota - A modulator of the Trypanosoma cruzi-vector-host triadIsabella Márcia Soares Nogueira Teotônio, Nayra Dias, Luciana Hagström-Bex, et al.Antimicrobial Agents and Chemotherapy|May 5, 2025
Intermittent suppressive posaconazole therapy is ineffective at mitigating cardiac and digestive tract pathologies in an experimental model of chronic Chagas diseaseShiromani Jayawardhana, Francisco Olmo, Amanda Fortes Francisco, et al.Plos Neglected Tropical Diseases|October 3, 2022
Comparing in vivo bioluminescence imaging and the Multi-Cruzi immunoassay platform to develop improved Chagas disease diagnostic procedures and biomarkers for monitoring parasitological cureAmanda Fortes Francisco, Ursula Saade, Shiromani Jayawardhana, et al.Pageof 4